Parallel Microscopic Determination of Fitness (PMDF) to Assess Growth and Viability of Mycobacterium tuberculosis
Parallel Microscopic Determination of Fitness (PMDF) to Assess Growth and Viability of Mycobacterium tuberculosis
批准号:
9089849
负责人:
DAVID R SHERMAN
金额:
$23.63万
依托单位国家:
美国
项目类别:
财政年份:
2015
资助国家:
美国
项目状态:
已结题
起止时间:
2015-06-15 至 2018-05-31
关键词:
AntibioticsAntitubercular AgentsAreaBacteriaBenchmarkingBiologicalBiologyCarbonCellsChemicalsCholesterolClinicalColony-forming unitsDataDepositionDevelopmentDiseaseEnvironmentEventGoalsGrowthHealthHeatingHeterogeneityImmuneIndividualLifeMasksMetabolicMethodologyMethodsMicrofluidicsMicroscopicMicroscopyMinimum Inhibitory Concentration measurementModificationMolecular and Cellular BiologyMonitorMycobacterium smegmatisMycobacterium tuberculosisNatural HistoryNutrientPharmaceutical PreparationsPhasePhase-Contrast MicroscopyPhenotypePopulationPreclinical Drug EvaluationPredispositionProcessProtocols documentationProxyReagentResearchSeriesSoilSolidSourceStaining methodStainsStressTechnologyTestingTimeValidationWorkbacterial resistancebactericidedrug discoveryfitnessimprovedkillingsmicroorganismnovelnovel strategiesnovel therapeuticspathogenpressureprogramsresearch studyresponsesmall moleculetime use
中文摘要
英文摘要
DESCRIPTION (provided by applicant): Despite many recent advances in understanding the molecular and cellular biology of Mycobacterium tuberculosis (MTB), the rate-limiting step in nearly all experiments remains batch-culture growth and phenotyping - an imprecise process of modest throughput that masks the heterogeneity of responses and is largely unchanged in the last 100 years. Like all bacteria, Mycobacterium tuberculosis (MTB) is subjected to dynamic environmental stresses throughout its natural history. Faced with varied and changing environments, bacteria respond in diverse ways - and the breadth of these responses cannot be captured in batch culture. Here we propose to develop a novel and robust method, Parallel Microscopic Determination of Fitness (PMDF), to monitor bacterial growth and viability while preserving and recording phenotypic heterogeneity within the population. We have performed pilot experiments using time lapse phase and fluorescent microscopy to monitor growth of the soil saprophyte Mycobacterium smegmatis, following the independent fates of thousands of separate cell deposition events in each experiment. Our goal now is to adapt this experimental platform to MTB, with a series of proof-of-concept experiments. We will characterize the replication of geographically diverse clinical isolates of MTB as they respond over time to defined, disease- relevant environmental perturbations, and develop this approach to improve analysis of susceptibility to small molecule antitubercular agents.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
Drug tolerance, bacterial heterogeneity and adverse TB treatment outcomes
-
批准号:10665037
-
项目类别:
-
资助金额:$13.32万
-
财政年份:2021
-
负责人:DAVID R SHERMAN
-
依托单位:
A multifactorial pipeline to dissect combinatorial drug efficacy in Tuberculosis
-
批准号:10117593
-
项目类别:
-
资助金额:$73.08万
-
财政年份:2021
-
负责人:DAVID R SHERMAN
-
依托单位:
Drug tolerance, bacterial heterogeneity and adverse TB treatment outcomes
-
批准号:10493290
-
项目类别:
-
资助金额:$14.37万
-
财政年份:2021
-
负责人:DAVID R SHERMAN
-
依托单位:
A multifactorial pipeline to dissect combinatorial drug efficacy in Tuberculosis
-
批准号:10669196
-
项目类别:
-
资助金额:$72.12万
-
财政年份:2021
-
负责人:DAVID R SHERMAN
-
依托单位:
A multifactorial pipeline to dissect combinatorial drug efficacy in Tuberculosis
-
批准号:10465068
-
项目类别:
-
资助金额:$70.51万
-
财政年份:2021
-
负责人:DAVID R SHERMAN
-
依托单位:
Drug tolerance, bacterial heterogeneity and adverse TB treatment outcomes
-
批准号:10271651
-
项目类别:
-
资助金额:$56.87万
-
财政年份:2021
-
负责人:DAVID R SHERMAN
-
依托单位:
Drug tolerance, bacterial heterogeneity and adverse TB treatment outcomes
-
批准号:10907961
-
项目类别:
-
资助金额:$33.99万
-
财政年份:2021
-
负责人:DAVID R SHERMAN
-
依托单位:
Project 2: Response to Treatment
-
批准号:10339374
-
项目类别:
-
资助金额:$74.61万
-
财政年份:2018
-
负责人:DAVID R SHERMAN
-
依托单位:
Bacterial Determinants of TB Progression
-
批准号:8577274
-
项目类别:
-
资助金额:$58.47万
-
财政年份:2013
-
负责人:DAVID R SHERMAN
-
依托单位:
Data Management and Resource Dissemination Core
-
批准号:8577291
-
项目类别:
-
资助金额:$17.88万
-
财政年份:2013
-
负责人:DAVID R SHERMAN
-
依托单位:
2013 Tuberculosis Drug Development GRC
-
批准号:8520841
-
项目类别:
-
资助金额:$0.8万
-
财政年份:2013
-
负责人:DAVID R SHERMAN
-
依托单位:
2011 Gordon Research Conference on Tuberculosis Drug Development
-
批准号:8125495
-
项目类别:
-
资助金额:$0.8万
-
财政年份:2011
-
负责人:DAVID R SHERMAN
-
依托单位:
A Novel Clock to Monitor M. tuberculosis in vivo
-
批准号:7844978
-
项目类别:
-
资助金额:$24.1万
-
财政年份:2009
-
负责人:DAVID R SHERMAN
-
依托单位:
A Novel Clock to Monitor M. tuberculosis in vivo
-
批准号:7574365
-
项目类别:
-
资助金额:$26.47万
-
财政年份:2009
-
负责人:DAVID R SHERMAN
-
依托单位:
Hypoxia, Latency and Reactivation in M.tuberculosis
-
批准号:7016314
-
项目类别:
-
资助金额:$32.87万
-
财政年份:2002
-
负责人:DAVID R SHERMAN
-
依托单位:
Hypoxia, Latency and Reactivation in M.tuberculosis
-
批准号:6655602
-
项目类别:
-
资助金额:$34.88万
-
财政年份:2002
-
负责人:DAVID R SHERMAN
-
依托单位:
Hypoxia, Latency and Reactivation in M.tuberculosis
-
批准号:6857094
-
项目类别:
-
资助金额:$33.68万
-
财政年份:2002
-
负责人:DAVID R SHERMAN
-
依托单位:
Hypoxia, Latency and Reactivation in M.tuberculosis
-
批准号:6450621
-
项目类别:
-
资助金额:$16.66万
-
财政年份:2002
-
负责人:DAVID R SHERMAN
-
依托单位:
Hypoxia, Latency and Reactivation in M.tuberculosis
-
批准号:6725521
-
项目类别:
-
资助金额:$35.1万
-
财政年份:2002
-
负责人:DAVID R SHERMAN
-
依托单位:
Hypoxia, Latency and Reactivation in M tuberculosis
-
批准号:6346504
-
项目类别:
-
资助金额:$32.15万
-
财政年份:2001
-
负责人:DAVID R SHERMAN
-
依托单位:
海外基金